How to Request a Silica Quote: Information Suppliers Need for Accurate Pricing

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Micro Silica? Properties, Specifications and Uses in Concrete and Refractories
  • Keywords: PPG Hi-Sil
  • Published: 2026-11-20 07:45:30
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Respirable Crystalline Silica OSHA Standard: Exposure Limits and Compliance Requirements

Calcium Carbonate Filler vs Silica: Performance, Cost and Applications Compared
The immune activation through functional nanocarriers is realized by interactions with innate immune cells such as macrophages, neutrophils, and complement proteins. Immune recognition triggers inflammation, immune responses, or even swift clearance, thus presumably constraining therapeutic effects. Surface properties, such as chemical composition, topography, and charge, may influence the immune cell activation and binding specificity. The possible immune interactions need to be well characterized for the development of stealth and immunocompatible nanoparticles [ 82 ]. Immune-derived side influences, such as cytokine release and complement activation, potentially corrupt the safety and the effectiveness of drug delivery [ 80 ]. Other problems that may affect nanoparticle penetration and the effectiveness of targeting are the heterogeneity of the target tissue and tumor microenvironment. Problems of stability, biodegradation rates, and nanoparticle agglomeration may also affect the effectiveness of action [ 80 ].
What Is the Common Name for Silicon Dioxide? Silica, Quartz and Other Names
Wet granulation is the most frequently used technique to process MSNs, because of the many possibilities inherent in it [ 106 ]. Conventional wet granulation is well-suited for the granulation of silica nanocarriers, but several things should be considered during implementation. There are two possible sequences: first, the drug loading, followed by the granulation of the loaded carriers [ 104 ], or the opposite way, the granulation of the empty carriers, then loading the drug into the prepared granules. In the first case, during the planning and implementation of the process, special attention must be paid to the critical process parameters to steer clear of premature drug release [ 104 ]. In general, it can be noted that as little moisture as possible should be used during granulation, consequently decreasing the risk of premature drug release. Still, simultaneously, moisture adequate to produce the desired agglomeration must be made sure [ 104 ]. The risk of premature drug release depends to a certain extent on the chemical structure of the API and the carrier. Szewczyk and Prokopowicz developed doxycycline-loaded MSN pellets with prolonged release kinetics [ 40 ]. First, the drug was loaded into the pores, and then pellets were produced from the loaded mesoporous material with other excipients by wet extrusion and spheronization. For comparison, traditional doxycycline pellets were also prepared. This study demonstrated the importance of utilizing mesoporous carriers for the delayed or sustained release of water-soluble drugs. Pelletization was a successful method to reduce the initial burst release of doxycycline; twice the release time was observed compared to traditional pellets [ 40 ]. Szewczyk et al. developed another DDS loaded with an antibiotic compound (cefazolin) for the treatment of osteomyelitis [ 66 ]. The amine-functionalized MSN was successfully loaded with the drug, and because of the powerful interactions between the negatively charged cefazolin and the positively charged surface of the carrier, a prolonged release of 5 days was observed, which made sure a longer antibacterial influence than with classic pellets. This was proven by the microbiological activity assays of the pellets against S. aureus culture [ 66 ]. These results are promising in antibiotic or anticancer therapy, where therapeutic concentration is needed for a longer period [ 40, 66 ]. A comparable outcome was presented in another publication about metformin-containing MSN pellets with prolonged release kinetics [ 85 ]. After drug loading, pellets were formed with the mixture of the preloaded carriers and chitosan solution, and then the pellets were coated with five layers of chitosan. Since the stomach is not considered the best possible absorption surface for metformin, it is advisable to delay the release until conditions in the intestines are ideal for maximum bioavailability. Chitosan plays an important role in this formulation; it slows down and delays the metformin release and offers delayed and prolonged release kinetics, thereby preventing speedy blood level peaks after application [ 85 ]. On the contrary, Wang et al. published a post on MSN pellets filled with poorly water-soluble carbamazepine, and they observed better oral bioavailability compared to commercially available tablets based on in vivo analysis performed on dogs [ 86 ]. In vitro dissolution studies confirmed a raised dissolution rate compared to crystalline carbamazepine due to the amorphous state of the drug within the pores. This immediate-release pellet formulation allows for a reduction in the drug dose, sustaining the same clinical influence [ 86 ].
Silica as a Flow Agent: How It Improves Powder Flowability
Novoray: Company Overview, Spherical Silica Products and Applications
54. Richter M., Welzmiller S., Monsuur F., Völp A.R., Quadflieg J. Dry Amorphization of Itraconazole Using Mesoporous Silica and Twin-Screw Technology. Pharmaceutics. 2024;16:1368. doi: 10.3390/pharmaceutics16111368. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]

Silica Market Size 2026: Global Value, Growth Rate and Key Segments

What is silica (SiO₂)?

silica dielectric constant Table 1.

What is the difference between fumed silica and precipitated silica?

silica in makeup powder

What drives silica raw material prices?

INS 551 In the case of solvent-free processes, the main advantage is that it is not necessary to get rid of the solvent residue from the system at the conclusion of the process, and the concentration of the API can also be controlled [ 36, 37 ]. Techniques employed in this class comprise physical mixing, co-milling, and melt sorption methods. The simplest approach is physical mixing [ 37 ], where fast drug filling is possible without special equipment. During direct mixing of the mesoporous carrier and the drug, the silanol groups on the surface of the silica bind the drug molecules. Nonetheless, its application is limited because it can be used largely for water-soluble molecules [ 37, 56 ]. Another method is co-milling, during which the mixture of the API and the nanocarrier is milled together [ 36, 37, 56 ]. In the case of the melt sorption method, the mixture of the API and the carrier system is heated above the melting point of the API under continuous stirring, while the melt is absorbed into the pores [ 36, 37 ]. After that, the system is cooled under lowered pressure, so that the molecules will be in an amorphous state in the pores [ 36, 37 ]. Nevertheless, this technique cannot be used in the case of heat-sensitive materials, due to the considerable thermal decomposition [ 20 ]. Microwave radiation can also be used for melting [ 2, 36 ].

Cite this article: Silica Raw Materials News. "Silica as an Excipient: Functions, Grades and Pharmaceutical Applications ." Published 2026-11-20 07:45:30. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.